TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #Immunology--TRexBio Inc., a discovery stage company decoding tissue immune biology to create revolutionary therapeutics, today announced that it has entered into a multi-year research collaboration and licensing agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration with...

Click to view original post